These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8568135)

  • 1. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study.
    Andri L; Senna G; Betteli C; Givanni S; Andri G; Dimitri G; Falagiani P; Mezzelani P
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):34-41. PubMed ID: 8568135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form.
    Andri L; Senna G; Andri G; Dama A; Givanni S; Betteli C; Dimitri G; Falagiani P; Mezzelani P
    Clin Exp Allergy; 1995 Nov; 25(11):1092-9. PubMed ID: 8581842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen.
    D'Amato G; Lobefalo G; Liccardi G; Cazzola M
    Clin Exp Allergy; 1995 Feb; 25(2):141-8. PubMed ID: 7750006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract.
    Bousquet J; Hejjaoui A; Skassa-Brociek W; Guérin B; Maasch HJ; Dhivert H; Michel FB
    J Allergy Clin Immunol; 1987 Oct; 80(4):591-8. PubMed ID: 3668124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal grass pollen immunotherapy increases T
    Slovick A; Douiri A; Muir R; Guerra A; Tsioulos K; Hay E; Lam EPS; Kelly J; Peacock JL; Ying S; Shamji MH; Cousins DJ; Durham SR; Till SJ
    J Allergy Clin Immunol; 2017 Jun; 139(6):1830-1839.e13. PubMed ID: 27773851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T; Latif L; Petersson-Westin U; Cardell LO
    J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
    Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H
    J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts.
    Bousquet J; Becker WM; Hejjaoui A; Chanal I; Lebel B; Dhivert H; Michel FB
    J Allergy Clin Immunol; 1991 Jul; 88(1):43-53. PubMed ID: 2071784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.
    Bousquet J; Hejjaoui A; Soussana M; Michel FB
    J Allergy Clin Immunol; 1990 Feb; 85(2):490-7. PubMed ID: 2406327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal immunotherapy at constant dosage: a double-blind, placebo-controlled study in grass-allergic rhinoconjunctivitis.
    Pocobelli D; Del Bono A; Venuti L; Falagiani P; Venuti A
    J Investig Allergol Clin Immunol; 2001; 11(2):79-88. PubMed ID: 11642577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal immunotherapy in pollen-sensitive children.
    Cserháti E; Mezei G
    Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
    Bertoni M; Cosmi F; Bianchi I; Di Berardino L
    Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
    Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
    JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass.
    Bozek A; Kolodziejczyk K; Krajewska-Wojtys A; Jarzab J
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):156-61. PubMed ID: 26815709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term efficacy of nasal immunotherapy.
    Palma-Carlos AG; Santos AS; Pregal A
    Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
    Senna GE; Andri G; Dama AR; Falagiani P; Andri L
    Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.